Bank of America
MTACU

Bank of America’s MedTech Acquisition Corporation Unit MTACU Stock Holding History

Bank of America’s Portfolio MTACU Stock Details MTACU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,153
Closed -$12K – 8840
2021
Q3 		$12K Buy
+1,153
New +$11.6K ﹤0.01% 7534

Other funds holding MTACU

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
BCL
Bracebridge Capital LLC Boston, Massachusetts $3.73B AUM 33.02% 1-Year Est. Return
ZCA
Zeke Capital Advisors Berwyn, Pennsylvania $1.53B AUM 17.37% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
LCM
Landscape Capital Management Englewood, New Jersey $1.54B AUM 30.95% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America's MTACU Position: Q4 2021 in Review

Bank of America sold out of MedTech Acquisition Corporation Unit (MTACU) in Q4 2021, closing a stake of 1,153 shares — an estimated $12K sold.

Bank of America first reported a position in MTACU in Q3 2021 and held it in 1 quarter. The position peaked at $12K in Q3 2021. 11 funds tracked by Wall St. Rank hold MTACU as of Q4 2021.

  • Bank of America reported no remaining MedTech Acquisition Corporation Unit position as of Q4 2021 after selling out during the quarter.
  • Bank of America sold 1,153 MedTech Acquisition Corporation Unit shares in Q4 2021, an estimated $12K.
  • Bank of America first reported a position in MedTech Acquisition Corporation Unit in Q3 2021 and held it in 1 quarter.
  • Bank of America's MedTech Acquisition Corporation Unit position peaked at $12K in Q3 2021.
  • 11 funds tracked by Wall St. Rank held MedTech Acquisition Corporation Unit as of Q4 2021.

Based on Bank of America's 13F filing for Q4 2021, filed 8 Feb 2022.